Title : PI3K inhibitor 3-MA promotes the antiproliferative activity of esomeprazole in gastric cancer cells by downregulating EGFR via the PI3K/FOXO3a pathway.

Pub. Date : 2022 Apr

PMID : 35228068






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PI3K inhibitor 3-MA promotes the antiproliferative activity of esomeprazole in gastric cancer cells by downregulating EGFR via the PI3K/FOXO3a pathway. Esomeprazole epidermal growth factor receptor Homo sapiens
2 ESO inhibited PI3K/AKT/FOXO3a signaling and EGFR and SKP2 expression concentration-dependent. Esomeprazole epidermal growth factor receptor Homo sapiens
3 Furthermore, pretreatment with the EGFR inhibitor AG1478 enhanced the antiproliferative activity of ESO in gastric cancer cells. Esomeprazole epidermal growth factor receptor Homo sapiens
4 In conclusion, our results suggested that the PI3K inhibitor 3-MA promotes the antiproliferative activity of ESO in gastric cancer cells by synergistically downregulating EGFR via the PI3K/FOXO3a pathway. Esomeprazole epidermal growth factor receptor Homo sapiens